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Objective: To investigate the effect of including seafood and fish oils, as part of an energy-restricted diet, on weight loss in
young overweight adults.
Design: Randomized controlled trial of energy-restricted diet varying in fish and fish oil content was followed for 8 weeks.
Subjects were randomized to one of four groups: (1) control (sunflower oil capsules, no seafood); (2) lean fish (3150 g
portions of cod/week); (3) fatty fish (3 150 g portions of salmon/week); (4) fish oil (DHA/EPA capsules, no seafood). The
macronutrient composition of the diets was similar between the groups and the capsule groups, were single-blinded.
Subjects: A total of 324 men and women aged 20–40 years, BMI 27.5–32.5 kg/m2 from Iceland, Spain and Ireland.
Measurements: Anthropometric data were collected at baseline, midpoint and endpoint. Confounding factors were accounted
for, with linear models, for repeated measures with two-way interactions. The most important interactions for weight loss were
(diet energy intake), (genderdiet) and (gender initial-weight).
Results: An average man in the study (95 kg at baseline receiving 1600 kcal/day) was estimated to lose 3.55 kg (95% CI, 3.14–
3.97) (1); 4.35 kg (95% CI, 3.94–4.75) (2); 4.50 kg (95% CI, 4.13–4.87) (3) and 4.96 kg (95% CI, 4.53–5.40) on diet (4) in 4
weeks, from baseline to midpoint. The weight-loss from midpoint to endpoint was 0.45 (0.41–0.49) times the observed weight
loss from baseline to midpoint. The diets did not differ in their effect on weight loss in women. Changes in measures of body
composition were in line with changes in body weight.
Conclusion: In young, overweight men, the inclusion of either lean or fatty fish, or fish oil as part of an energy-restricted diet
resulted in B1 kg more weight loss after 4 weeks, than did a similar diet without seafood or supplement of marine origin. The
addition of seafood to a nutritionally balanced energy-restricted diet may boost weight loss.
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Introduction
Obesity has become a serious worldwide healthcare problem,
which is becoming increasingly prevalent among young
adults and children.1,2 It is therefore of great importance to
help young overweight adults to lose weight. Inclusion of fish
in a weight-loss-diet has been shown to have positive effects
on several health-related variables,3,4 which could be due to
n-3 fatty acids or other seafood constituents, such as fish
proteins as reported in animal studies.5–7 Beneficial effects of
fish consumption in relation to cardiovascular health have
been thoroughly described, and mainly attributed to n-3 fatty
acids.8–11 Studies in rodents have demonstrated that marine
n-3 fatty-acid-enriched diet decrease adipose growth and
increase b-oxidation.12,13 Additionally, taurine, an amino
acid abundant in fish protein, has been suggested to decrease
body weight.14 The impact of including fish or a supplement
of marine origin, in a weight loss diet, on the efficacy of such
diets in humans has not been investigated to date.
The aim of the present study was to investigate the specific
effects of seafood consumption on weight loss in young
overweight adults, by comparing energy-restricted diets
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which were similar in terms of their energy content and
macronutrient composition and contained either, lean fish,
fatty fish, supplemental fish oil capsules or supplemental
placebo capsules. We conducted a randomized controlled
trial in three European countries, with weight loss as the
main outcome.
Subjects and methods
The study was a randomized 8-week intervention trial of four
isocaloric diets in three European countries: Iceland, Spain
and Ireland. The study is part of a large multicenter study,
funded by the European Union: SEAFOODplus – a better life
with seafood (see www.seafoodplus.org). SEAFOODplus-
YOUNG is a Research and Technology Development (RTD)
project in Pillar 1 (Seafood and Human Nutrition) of
SEAFOODplus.
Participants
Subjects were recruited through advertisements. Recruitment
of 320 subjects (140 from Iceland, 120 from Spain and 60
from Ireland) was planned; it was estimated that a 70–80%
participation allowed a detection of approximately 1 kg
difference in weight loss between the four diet groups,
assuming a standard deviation (s.d.) of 3 kg, a significance P-
value of 0.05 and a statistical power of 0.8. All potential
subjects that answered the call were screened for inclusion
and exclusion criteria, first over the phone and then in
person. Initially 324 subjects (138 men and 186 women)
were included. The inclusion criteria were body mass index
(BMI) 27.5–32.5 kg/m2, age 20–40 years, and a waist
circumference of X94 cm and X80 cm for men and women,
respectively. Exclusion criteria were weight change due to
weight-loss diet within 3 months before the start of the
study, use of supplements containing n-3 fatty acids, calcium
or vitamin-D during the last 3 months, drug treatment of
diabetes mellitus, hypertension or hyperlipidemia and
women’s pregnancy or lactation. Recruitment was under-
taken during 2004 and 2005. The study was approved by the
National Bioethical Committee in Iceland (04–031), the
Ethical Committee of the University of Navarra in Spain (24/
2004) and the Clinical Research Ethics Committee of the
Cork University Hospital in Ireland. The study followed the
Helsinki guidelines and all subjects participating gave their
written consent.
Protocol
The subjects had at least three visits to the clinic during the
8-week trial, at baseline, mid- and endpoint. Additionally,
they were contacted on at least two other occasions by
phone and/or email, in weeks 2 and 6. The subjects were also
encouraged to contact the clinic on their own initiative if
they had any questions regarding the research during the 8-
week intervention period. At baseline, mid- and endpoint
visits they met a nutritionist, anthropometric measurements
were performed and seafood intake was assessed by a
validated food frequency questionnaire (FFQ).15 Dietary
intake was assessed by 2-day weighed food records before
baseline (habitual diet) and in week 6 or later during the last
2 weeks of the intervention trial. At baseline, information on
physical activity patterns during the previous year, smoking
habits and alcohol consumption was collected using a
questionnaire.16 Subjects were instructed not to change their
physical activity level during the 8-week intervention period
and to keep their alcohol consumption to a minimum (max
1 drink of wine or beer per week).
The dietary records were analyzed using the food composi-
tion database in each country. Compliance with the inter-
vention diets was assessed by the 2-day weighed food
records, by the validated FFQ and also by analyzing n-3
and n-6 fatty acids in erythrocyte phospholipids in fasting
blood samples from the subjects. Results showed good
compliance with the intervention diets.
Dietary intervention
Basal metabolic rate was estimated by applying Harris–
Benedict equations,17 and a correction factor due to the
overweight status of the subjects.18 To estimate total energy
expenditure, the physical activity level was set to 1.3, as a
relatively low physical activity level was reported by all
subjects.19 Each subject was instructed to follow a diet,
energy restricted by 30% from estimated energy expenditure
(approximately 600 kcal/day), for eight consecutive weeks.
The subjects were randomly assigned to four diets (see
Table 1) varying in types of dietary protein and amount of n-
3 fatty acids (especially very long-chain n-3 fatty acids): diet
(1) no seafood (control, including 6 placebo capsules/day
Loders Croklaan (Lipid Nutrition), Wormerveer, The Nether-
lands, encapsulated by Banner Pharmacaps, Tilburg, The
Netherlands); diet (2) lean fish (150 g cod3/week, Samher-
ji, Iceland); diet (3) fatty fish (150 g salmon3/week, Marine
Harvest, Nutreco, Norway); or diet (4) fish oil capsules
(6 capsules/day, Loders Croklaan (Lipid Nutrition), Wormerv-
eer, The Netherlands, encapsulated by Banner Pharmacaps,
Tilburg, The Netherlands). The diets were similar in total fat
(30% of total energy), carbohydrate (50% of total energy),
protein (20% of total energy) and dietary fiber (20–25 g).
Table 1 Fatty acids (%) in erythrocyte phospholipids of subjects at endpoint
in each diet group (n¼ 278)
Diets Erythrocyte
phospholipids n-3
fatty acids (%)
Erythrocyte
phospholipids n-6
fatty acids (%)
Control capsules, 6 per day 9.9 (2.5) 29.5 (4.1)
Cod 150 g three times per week 10.8 (2.4) 29.7 (4.0)
Farmed salmon 150 g three times
per week
12.2 (2.3) 28.3 (3.6)
Fish oil capsules, 6 per day 12.7 (2.9) 29.5 (3.3)
The values are mean (s.d.).
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Each subject got a detailed meal plan to follow for 8 weeks, as
well as recipe booklets and instructions to minimize
difference between diets in sources of fat, fruit and vegetable
consumption and meal frequency.
Fatty-acid analysis
The proximate chemical composition of the fish used in the
study was carried out according to AOAC methods20 and
fatty acid determination followed the conditions described
by Bandarra et al.21 Absolute values were calculated using the
corrective factors proposed by Weihrauch et al.22 The
culinary treatments were carried out following usual house-
hold methods. True retention factors were calculated for
total n-3 fatty acids.23 The n-3 content of the cod (in diet 2)
was 0.3 g/day, the salmon (in diet 3) 3.0 g/day and the fish oil
capsules (in diet 4) 1.5 g/day. Other sources of n-3 fatty acids
were congruent between diet groups. Table 1 shows results
from analysis of n-3 and n-6 analysis of erythrocyte
phospholipids. The n-6 fatty acids in red blood cells of
individuals on the four different diets showed similar values.
The percentage of n-3 fatty acids in erythrocyte phospholi-
pids was similar in diets (3) and (4) despite higher intake of
group (3) according to the fatty-acid analysis of the salmon
and fish oil capsules.
Anthropometric measurements
Anthropometric measurements were performed on three
occasions during the 8-week period: at baseline, midpoint
and endpoint. Weight was measured in light underwear on a
calibrated scale (SECA 708, Germany) in all centers. Height
was measured with a calibrated stadiometer, and waist and
hip circumferences were measured following standardized
methods. Fat mass and fat-free mass were assessed by
bioelectrical impedance analysis (Bodystat 1500, Bodystat
Ltd, UK). All measurements were carried out using standard
measurement procedures as outlined in the research protocol
used by each of the three countries participating in the study.
Statistical analysis
Mean and s.d. were used to describe the data. The unadjusted
difference in weight loss and changes of other anthropo-
metric measurements between the control group and
treatments groups was assessed by independent sample t-
test. The individuals included in the study were young,
healthy adults, except for their overweight or obesity, and
hence a normal model was the natural candidate. A linear
model for the response in a repeated measures analysis for
the difference was set up. The important main effects were
assumed to be diet, gender, initial body weight and country.
Owing to cultural differences, it was conceivable that there
might be interactions between country and diet, as seafood
may play a different role in the national diets. Genders may
differ in compliance as well as in the response. Therefore, to
evaluate the impact of the dietary experiment, the use of
linear models for repeated measures with two-way interac-
tions was the approach of choice. The most important
interactions were found to be (gender initial-weight),
(genderdiet) and (diet calories), giving an F-value of 89,
which is highly significant. The F-value of other two-way
interactions was 0.79, which is not significant.
The quality of the model was evaluated by residual
diagnosis. If the response to treatment is normally distrib-
uted then skewness of residuals should be around zero and
kurtosis around 3. The skewness for weight reduction was
0.05 for males and –0.13 for females, and the kurtosis was 2.5
and 3.2 for men and women, respectively, showing that the
normal approximation is reasonable. If modelling is success-
ful residuals should also show irregular patterns when
plotted against various variables and transformations of
them. Traditional residual diagnostics were performed. The
dropout process was modelled with a binary response model.
The impact of the covariates on the probability of dropout
was evaluated by a logistic regression. Correlations between
weight loss and decrease in other anthropometric variables
were illustrated by Spearman’s rank correlation analysis.
Results
Baseline characteristics and dropouts
Of a total of 324 randomized individuals to enter into the
trial, 278 (86%) completed the randomized intervention.
Figure 1 shows the flow of participants. The two most
common reasons for dropout were that the subject was
unable to follow the restricted diet and/or lack of time to
maintain the schedule of clinical visits. The results of the
logistic regression suggest no systematic explanation of
dropout. Dropouts were equally distributed between inter-
vention diet groups and variables predicting weight loss in
the present study were not different between dropouts and
those who completed the trial. The baseline characteristics of
the subjects are shown in Table 2.
Dietary intake
Habitual dietary intake was assessed by a 2-day food record at
baseline before randomization and compliance with the
324 randomised
80 assigned to
diet group (2)
10 droped out
84 assigned to
diet group (3)
10 droped out
80 assigned to
diet group (4)
12 droped out
Endpoint data
obtained from
68 in diet
group (4)
Endpoint data
obtained from
74 in diet
group (3)
Endpoint data
obtained from
70 in diet
group (2)
Endpoint data
obtained from
66 in diet
group (1)
80 assigned to
diet group (1)
14 droped out
Figure 1 Flow of participants in the study.
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dietary intervention was assessed between weeks 6 and 8.
Energy intake was not different between the four interven-
tion diet groups, neither at baseline nor during the inter-
vention. The mean habitual energy intake at baseline was
2022 kcal/day (522 s.d.) among women and 2694 kcal/day
(837 s.d.) among men. The intervention diets gave on
average 1350 kcal/day (318 s.d.) and 1579 kcal/day (363 s.d.)
for women and men, respectively. The contribution of
energy-giving nutrients (E%) was not different between the
intervention diets except for dietary proteins where a small
but significant difference was observed (20E% in diet groups
(2) and (3) compared with 18E% and 19E% in diet groups (1)
and (4), respectively).
Weight loss
The average reduction in weight was 6.5 kg (s.d.¼3.3 kg) for
men and 4.2 kg (s.d.¼2.4 kg) for women. Table 3 shows the
mean unadjusted decrease in weight, body mass index (BMI)
and other anthropometric measurements in the four groups.
Weight loss and decrease in waist circumference was
significantly greater in the groups receiving fish or fish oil
(cod, salmon or fish oil) when compared with the control
group (Po0.05), but in male subjects only.
We chose to use a modelling approach to assess any true
difference in weight loss across the intervention diets. This
was done to adjust for baseline values and the fact that men
and women were not equally distributed in the groups. The
base model was taken as:
Weight loss ¼main effects þ ½genderinitial weight
þ½genderdiet þ ½dietenergy intake
The expected weight loss for an average man (96 kg, assigned
to a diet giving1600 kcal/day) after the first 4 weeks of the
study, calculated from the model output in Table 4, was
3.55 kg (95% CI, 3 14–3  97) on diet (1), 4.35 kg (95% CI,
3.94–4.75) on diet (2), 4.50 kg (95% CI, 4.13–4.87) on diet
(3), and 4.96 kg (95% CI, 4.53–5.40) on diet (4). The expected
weight loss for a male weighing 10 kg above the average is
1.60 kg more. Calculating average weight loss from the
Icelandic model, a Spanish subject would be expected to
lose 0.47 kg more and an Irish subject 0.80 kg less in every
diet group. No significant (countrydiet) interaction was
seen indicating that diet effects were similar across countries.
Diets did not differ in their effect on weight loss for females.
The expected weight loss for an average woman (82 kg)
assigned to a diet giving 1300 kcal/day did not differ between
the diet groups being 2.82 kg (95% CI, 2.48–3.16) on diet (1),
2.99 kg (95% CI, 2.64–3.34) on diet (2), 2.83 kg (95% CI,
2.47–3.18) on diet (3), and 3.03 kg (95% CI, 2.69–3.37) on
diet (4) in weeks 1–4. The most significant interaction was
the (gender initial weight) interaction. For men, the
Table 2 Characteristics of subjects at baseline (n¼ 324)
Group 1 (n¼ 80) Control Group 2 (n¼ 80) Lean fish Group 3 (n¼84) Fatty fish Group 4 (n¼ 80) Fish oil
Women (n¼48) Men (n¼32) Women (n¼ 45) Men (n¼35) Women (n¼42) Men (n¼ 42) Women (n¼ 51) Men (n¼29)
Weight (kg) 81.7 (6.7) 96.7 (7.2) 84.2 (7.3) 96.3 (7.4) 83.3 (6.9) 97.5 (10.6) 80.5 (7.0) 93.0 (7.8)
Height (m) 1.65 (0.06) 1.79 (0.06) 1.67 (0.06) 1.79 (0.06) 1.66 (0.06) 1.79 (0.08) 1.63 (0.05) 1.77 (0.07)
Body mass index (kg/m2) 29.9 (1.5) 30.1 (1.5) 30.2 (1.6) 30.2 (1.2) 30.3 (1.5) 30.5 (1.3) 30.1 (1.7) 29.5 (1.2)
Waist circumference (cm) 91.7 (6.1) 100.4 (6.0) 93.2 (6.1) 101.3 (4.4) 92.5 (7.6) 101.4 (5.3) 91.4 (6.4) 98.5 (4.4)
Hip circumference (cm) 111.5 (5.5) 108.9 (3.9) 113.5 (5.7) 107.8 (3.9) 111.9 (4.2) 109.5 (5.4) 110.5 (6.0) 107.2 (4.2)
Fat-free mass (kg) 49.3 (3.9) 72.0 (5.2) 51.3 (5.8) 71.0 (5.5) 51.3 (5.1) 71.9 (7.4) 49.9 (6.9) 69.5 (6.3)
Fat mass (kg) 32.8 (4.7) 24.6 (3.8) 32.9 (4.9) 25.3 (3.3) 32.5 (4.1) 25.5 (4.5) 31.8 (4.4) 23.5 (3.6)
Values are means (s.d.). No differences in anthropometric measurements were observed between diet groups at baseline.
Table 3 Decrease in body weight and other anthropometric measurements
from baseline after 8-weeks intervention, unadjusted
Group 1 control
(42 women, 24
men)
Group 2 lean
fish (39 women,
31 men)
Group 3 fatty
fish (37 women,
37 men)
Group 4 fish oil
(40 women,
28 men)
Body weight (kg)
Women 3.9 (2.6) 4.4 (2.3) 3.9 (2.3) 4.4 (2.6)
Men 5.3 (3.0) 6.5 (2.8) 7.0 (3.5) 6.7 (3.6)
All 4.4 (2.8) 5.4 (2.7) 5.5 (3.3) 5.4 (3.2)
Body mass index (kg/m2)
Women 1.4 (1.0) 1.6 (0.8) 1.4 (0.9) 1.7 (1.0)
Men 1.6 (0.9) 2.1 (0.9) 2.2 (1.1) 2.1 (1.1)
All 1.5 (0.9) 1.8 (0.9) 1.8 (1.0) 1.9 (1.0)
Waist circumference (cm)
Women 3.8 (2.4) 4.0 (2.6) 4.1 (2.9) 3.8 (2.8)
Men 4.5 (2.3) 6.2 (2.8) 6.6 (3.2) 6.9 (2.7)
All 4.0 (2.4) 5.0 (2.9) 5.4 (3.3) 5.1 (3.1)
Hip circumference (cm)
Women 3.9 (2.7) 4.4 (2.4) 4.0 (2.1) 4.0 (2.5)
Men 2.7 (1.6) 3.8 (1.8) 4.6 (3.1) 4.0 (2.4)
All 3.5 (2.4) 4.2 (2.1) 4.3 (2.6) 4.0 (2.5)
Fat-free mass (kg)
Women 1.3 (2.4) 1.6 (2.7) 1.2 (1.2) 0.9 (1.2)
Men 2.1 (1.6) 2.5 (1.8) 2.8 (1.7) 2.6 (1.7)
All 1.6 (2.2) 2.0 (2.4) 2.0 (1.7) 1.6 (1.7)
Fat mass (kg)
Women 2.8 (2.2) 2.9 (2.9) 2.9 (1.8) 3.4 (2.1)
Men 3.2 (2.6) 4.0 (2.1) 4.2 (2.5) 4.2 (2.5)
All 3.0 (2.3) 3.4 (2.6) 3.5 (2.3) 3.7 (2.3)
Values are means (s.d.).
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expected weight loss was a function of initial weight, but this
was not the case for women. This means that weight at
baseline was positively related to actual weight loss (in kg) in
men, but not in women.
A significant (energy intakediet) interaction (see Table 4)
suggested that the impact of calorie reduction was not the
same across diets, where the impact seems to be larger in diet
group (2) than in the other diet groups.
For the period from weeks 5 to 8, a similar model was
estimated. Two variables were added to the model, observed
and predicted weight loss in the first period (weeks 1–4). The
results show that weight loss during weeks 1–4 was the only
significant factor that explained weight loss during weeks 5–
8. The estimated weight loss in weeks 5–8 was 0.45 (0.41–
0.49) times the observed weight loss in weeks 1–4.
Other anthropometric measurements
Strong correlations were seen between weight reduction and
reductions in other anthropometric measurements, both for
the first 4 and the last 4 weeks as seen in Table 5. The BMI of
males in diet groups (2), (3), (4) decreased more during the 8-
week intervention than the control, diet group (1). The
reduction of waist circumference was larger in diet group (4)
than in diet group (1), but the impact was small. It was
observed that reduction in all anthropometric measurements
in weeks 5–8 was predominantly predicted by weight
reduction in weeks 1–4.
Discussion
The important finding of the current study is that following
an energy-restricted diet for 8 weeks containing lean or fatty
fish or fish oil resulted in more weight loss than did an
isocaloric energy-restricted diet without marine food.
The effect of lean fish as part of an energy-restricted diet is
of specific interest as up to now the main hypothesis on the
health benefits of fish consumption has been contingent on
the effect of n-3 fatty acids. The current study indicates that
consuming a diet relatively low in n-3 fatty acids, but high in
quality fish proteins gives similar results as a diet rich in n-3
dietary fatty acids and quality fish proteins. If confirmed this
might be an important public health information, especially
since some populations consume more lean fish than fish
rich in n-3 fatty acids.14,23
Seafood-derived n-3 fatty acids, as those found in higher
amounts in diets (3) and (4) in the present study including
fatty fish or fish oil capsules, have been shown to decrease
the growth of the adipose cell, probably through stimulated
b-oxidation.12,13,24 Recently, this finding was supported by a
study on mice showing that the anti-adipogenic effect of
eicosapentaenoic and docoxahexaenoic acids may involve a
switch in adipocytes that includes increase in b-oxidation
and upregulation of mitochondrial biogenesis.25 Further-
more, a recent review by Madsen et al.26 also describes that n-
3 fatty acids may affect adipocyte differentiation. N-3
polyunsaturated fatty acids decrease adipose tissue mass
and the development of obesity in rodents by targeting a set
of key regulatory transcription factors involved in adipogen-
esis and lipid homeostasis.26 The same set of factors are
targeted by n-6 polyunsaturated fatty acids, but their effect
seem to be dependent on feeding status and hormonal
background and n-6 therefore react either as anti- or
proadipogenic agents.26 However, Garaulet et al.27 have
recently showed, for the first time in humans, that n-3 and
n-6 fatty acids are related to a reduced adipocyte size
according to the tissue localization. A specific effect of
seafood n-3 fatty acids may be responsible for more
reduction in body weight and associated anthropometric
variables of diets (3) and (4), including fatty fish or fish oil
capsules, compared to the diet without seafood or marine
oil, that is, control diet (1).
However, this cannot solely explain the similarly effective
lean fish diet, which had only slightly higher amounts of
total n-3 than the control diet (1) without seafood. Fish
proteins may be the candidate for this effect.5–7 Inclusion of
fish in a weight loss diet has been shown to have positive
Table 4 Parameter estimates of base model
E s.e t P
Intercept 11.71 4.77 2.46 0.01
Weight at baseline (kg) 0.16 0.03 5.54 0.00
Gender (women) 13.60 2.69 5.05 0.00
Energy intake, 1000 kcal 0.22 3.05 0.07 0.94
Country (Spain) 0.47 0.23 2.03 0.04
Country (Ireland) 0.80 0.27 2.96 0.00
Diet group (2), lean fish 14.75 5.89 2.50 0.01
Diet group (3), fatty fish 11.07 5.48 2.02 0.04
Diet group (4), fish oil 7.05 5.76 1.22 0.22
Baseline weight * gender (women) 0.15 0.03 5.20 0.00
Energy intake * diet group (2) 8.45 3.56 2.37 0.02
Energy intake * diet group (3) 6.13 3.31 1.85 0.07
Energy intake * diet group (4) 3.41 3.50 0.98 0.33
Gender (women) * diet group (2) 3.44 1.30 2.65 0.01
Gender (women) * diet group (3) 2.98 1.22 2.44 0.02
Gender (women) * diet group (4) 2.33 1.30 1.80 0.07
Example of how expected weight loss in diet group 4 (fish oil) the first 4 weeks
of the 8-week intervention is calculated for a female weighing 81.9 kg at
baseline (average weight at baseline), receiving 1320 kcal/day (average
energy intake of females in the trial): Expected weight loss¼ 11.71–
0.162*81.9–13.60+0.216*1.320–7.049+0.147*81.9+3.41*1.320+2.334.
Table 5 Correlation (Spearman r) between the decrease in body weight and
decrease in other anthropometric measurements from baseline to midpoint
(week 4), and from midpoint to end (week 8)
Weeks 1–4 Weeks 5–8
Decrease in body weight 1.0 1.0
Decrease in BMI 0.95 0.98
Decrease in waist circumference 0.60 0.60
Decrease in hip circumference 0.54 0.51
Decrease in fat free mass 0.60 0.60
Decrease in fat mass 0.76 0.71
Decrease in body fat percentile 0.55 0.46
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effects on several health-related variables in a study of 63
subjects,3,4,28 but to our knowledge, the effects of seafood to
increase weight loss in humans has not been seen before.
Inclusion of fish oil in a diet of six adults was found to reduce
body fat mass in a study by Couet et al.24 The results of the
present study may indicate that there are components of
fish, for example, particular combinations of amino acids
that may be beneficial to human health beyond the n-3 fatty
acids or other bioactive constituents. A plausible candidate is
taurine, an amino acid abundant in fish protein. An early
study showed that taurine decreases body weight in
hyperglycemic obese mice,14 and ingestion of 3 g taurine
per day for 7 weeks has been found to be associated with
weight loss in humans.29 Additionally, a recent study found
dietary taurine supplementation to prevent obesity in mice
by increased resting energy expenditure.30 Further studies
are needed to examine possible mechanisms. In addition,
closer investigation of the effects of portion size and more
frequent fish consumption as part of a varied and balanced
diet is required. For example, eating fish three times a week
would not have been regarded as exceptional in countries
like Iceland until relatively recently.
A gender difference was observed in the present study,
where the different effects of the intervention diets on
weight loss was specifically observed in men but not in
women. Furthermore, men lost weight in proportion to their
weight at baseline, but this effect was not observed in
women. This may partly be explained by the fact that
women naturally lost less, during the period of the study, as
30% energy restriction for women was less than for men in
absolute values, as their estimated energy requirement is
lower. Another potential explanation could be gender
difference in response to marine food, as the endogenous
conversion of a-linolenic acid into docosahexaenoic acid
seems to be greater in women than in men.31–32
An important finding in the present study was that
reduction in all anthropometric measurements in weeks 5–
8 was predominantly predicted by weight reduction in weeks
1–4. This could be interpreted that the weight loss in the first
4 weeks is a proxy variable for compliance to treatment, and
that those who comply in the first 4 weeks are more likely to
continue the treatment in weeks 5–8, resulting in additive
effects on anthropometric variables and potentially dimin-
ished risk for chronic diseases. Other studies have shown
that weight loss in the beginning of a weight reduction
program is an important determinant of further weight
loss.33–35 This could also be due to metabolic determinants.36
The results indicate that the loss of fat-free mass was greater
in the diet groups receiving fish. However, the distribution
was large and no significant difference observed in loss of fat-
free mass between the four diet groups.
The strength of the study is the design and it is the first
human randomized controlled trial to test effects on weight
loss from similarly energy-restricted diets containing lean
fish, fish rich in n-3 fatty acids and supplemental fish oil vs
diet containing no seafood. The statistical model designed to
describe effects on weight including important determinants
for weight loss is also of high value as it reflects the high
impact of gender and initial weight on the outcome, which
has to be taken into consideration. There is no reason to
believe that the results could not apply in similar popula-
tions other than in Iceland, Spain and Ireland as no
diet country interaction was found, showing that the
difference in weight loss between diet groups was seen to a
similar degree in all countries. Physical activity was assessed
during the intervention period and was found to be similar
between diet groups.
A limitation of the current study could be the inclusion of
both men and women, as they were found to react
differently. However, this could also be interpreted as an
additional benefit of the study, as the pronounced gender
difference was unexpected. Another limitation could have
been uncertainty in dietary intakes of subjects during the
study period, but as compliance was tested during the
intervention trial and overall results, red blood cell fatty
acid composition as well as total weight loss were as
expected, this risk was minimized. Probably the main
limitation of the study is the relatively short time period,
that is, 8 weeks, for observation. The reason for the short
time period lies in the main aim of the study, which was to
investigate if there was a possible difference between weight-
loss-diets that included and excluded food components of
marine origin. The study was not designed to assess long-
term effects, which we suggest should be considered in
future studies.
It remains a significant priority to help overweight
individuals to lose weight. How the weight loss is brought
about can make a difference to both total kg lost and to
reduction of cardiovascular risk factors. The subjects in the
present study were 20- to 40-year-old, which means that
some are parents or are likely to have children in the near
future. Parental influence on children’s dietary habits is well
known,37,38 and if fish consumption proves to be effective in
assisting weight reduction and improving weight mainte-
nance in humans, the 20–40 year age group is a key target
group for dietary interventions aimed to increase fish intake.
In conclusion, in young, overweight men, the inclusion of
either lean or fatty fish, or fish oil as part of a hypoenergetic
diet resulted in B1 kg more weight-loss after 4 weeks than
did a similar diet without seafood or supplement of marine
origin. The addition of seafood to a nutritionally balanced
energy-deficient diet may boost weight loss.
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